SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
Adenocarcinoma of Lung
/ diagnosis
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ analysis
DNA-Binding Proteins
/ analysis
Diagnosis, Differential
Female
GATA3 Transcription Factor
/ analysis
Humans
Lung Neoplasms
/ diagnosis
Mammaglobin A
/ analysis
Membrane Transport Proteins
/ analysis
Middle Aged
Receptors, Androgen
/ analysis
SOXE Transcription Factors
/ analysis
Transcription Factors
/ analysis
Triple Negative Breast Neoplasms
/ diagnosis
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
11
1
2019
medline:
10
1
2020
entrez:
11
1
2019
Statut:
ppublish
Résumé
Triple-negative breast cancer (TNBC) patients have an increased risk of developing visceral metastases and other primary nonbreast cancers, particularly lung cancer. The differential diagnosis of TNBC metastases and primary cancers from other organs can be difficult due to lack of a TNBC standard immunoprofile. We analyzed the diagnostic value of estrogen receptor, progesterone receptor, human epidermal growth factor receptor, thyroid transcription factor-1 (TTF1), Napsin A, mammaglobin, gross cystic disease fluid protein 15 (GCDFP15), Sry-related HMg-Box gene 10 (SOX10), GATA-binding protein 3 (GATA3), and androgen receptor in a series of 207 TNBC and 152 primary lung adenocarcinomas (LA). All tested TNBCs were TTF1 and Napsin A-negative. When comparing TNBC and TTF1-positive or negative LA, SOX10 had the best sensitivity (62.3%) and specificity (100%) as a marker in favor of TNBC compared with LA, irrespective of TTF1 status (P<0.0001). GATA3 had moderate sensitivity (30.4%) and excellent specificity (98.7%) and misclassified only 2/152 LA (1.3%). GCDFP15 had a moderate sensitivity (20.8%) and excellent specificity (98%) and misclassified only 3/152 (2%) LA. Mammaglobin and androgen receptor had moderate sensitivities (38.2% and 30%), good specificities (81.6% and 86%), and misclassified 28/152 and 21/152 LAs, respectively. In multivariate analysis, the best markers, enabling the distinction between SOX10-negative TNBC and TTF1 and Napsin A-negative LA were GATA3 (odds ratio=33.5; 95% confidence interval, 7.3-153.5; P<0.0001) and GCDFP15 (odds ratio=31.7; 95% confidence interval, 6.9-145.6; P<0.0001). Only 13/207 (6.3%) TNBC cases did not express any aforementioned marker. On the basis of our results, the best sequential immunohistochemical analysis to differentiate TNBC from TTF1-negative LA is first SOX10 followed by GATA3, and finally GCDFP15. This order is important in the diagnostic workup of small biopsies from lung nodules in women with a previous history of TNBC.
Identifiants
pubmed: 30628926
doi: 10.1097/PAS.0000000000001216
doi:
Substances chimiques
AR protein, human
0
Biomarkers, Tumor
0
DNA-Binding Proteins
0
GATA3 Transcription Factor
0
GATA3 protein, human
0
Mammaglobin A
0
Membrane Transport Proteins
0
PIP protein, human
0
Receptors, Androgen
0
SOX10 protein, human
0
SOXE Transcription Factors
0
TTF1 protein, human
0
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM